Qiagen NV (NYSE:QGEN)
| 50.00 Delayed Data As of Oct 27 |  +0.74 / +1.50%Today’s Change | 28.70 Today|||52-Week Range 55.27 | +47.93% Year-to-Date |
Latest QGEN News | Press Releases
| Qiagen (QGEN) Tops Q3 Earnings and Revenue Estimates Oct 27 / Zacks.com - Paid Partner Content | 3 MedTech Growth Stocks to Scoop Up Ahead of Q3 Earnings Oct 16 / Zacks.com - Paid Partner Content |
| Thermo Fisher's 3rd Quarter Boosted by Coronavirus Sales Oct 22 / GuruFocus News - Paid Partner Content | AnaptysBio (ANAB) Jumps: Stock Rises 7.7% Oct 16 / Zacks.com - Paid Partner Content |
| Align's (ALGN) ClinCheck Suite Now Commercially Available Oct 21 / Zacks.com - Paid Partner Content | IVERIC bio (ISEE) Catches Eye: Stock Jumps 6.8% Oct 16 / Zacks.com - Paid Partner Content |
| Intersect ENT (XENT) Posts Preliminary Q3 Data, Dull Q4 View Oct 20 / Zacks.com - Paid Partner Content | NeoGenomics (NEO) Looks Good: Stock Adds 5.5% in Session Oct 15 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights: Edwards Lifesciences, QIAGEN, IDEXX, LHC and ResMed Oct 19 / Zacks.com - Paid Partner Content | Boston Scientific Gets a Boost From MedSurg Arm Amid Coronavirus Oct 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 49.26 |
| Today’s open | 49.95 |
| Day’s range | 49.00 - 51.26 |
| Volume | 1,293,446 |
| Average volume (3 months) | 1,346,745 |
| Market cap | $11.6B |
Data as of 3:59pm ET, 10/27/2020
Growth & Valuation
| Earnings growth (last year) | -121.76% |
| Earnings growth (this year) | +47.10% |
| Earnings growth (next 5 years) | +10.74% |
| Revenue growth (last year) | +1.64% |
| P/E ratio | 833.3 |
| Price/Sales | 5.02 |
| Price/Book | 4.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WATWaters Corp | +3.66 | +1.66% |
| PKIPerkinElmer Inc | +2.91 | +2.35% |
| BIOBio Rad Laboratories... | +6.13 | +1.05% |
| BRKRBruker Corp | +0.64 | +1.52% |
Data as of 4:00pm ET, 10/27/2020
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | -$41.5M |
| Net profit margin | -2.72% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
